10 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 31337603 | PMPCB Silencing Sensitizes HCC Tumor Cells to Sorafenib Therapy. | 2019 Oct 2 | 1 |
2 | 27307592 | Sorafenib and Quinacrine Target Anti-Apoptotic Protein MCL1: A Poor Prognostic Marker in Anaplastic Thyroid Cancer (ATC). | 2016 Dec 15 | 1 |
3 | 24852430 | Tiam1 siRNA enhanced the sensitivity of sorafenib on esophageal squamous cell carcinoma in vivo. | 2014 Aug | 1 |
4 | 23231952 | Sorafenib inhibits cell migration and stroma-mediated bortezomib resistance by interfering B-cell receptor signaling and protein translation in mantle cell lymphoma. | 2013 Feb 1 | 1 |
5 | 22406995 | Sorafenib inhibits endogenous and IL-6/S1P induced JAK2-STAT3 signaling in human neuroblastoma, associated with growth suppression and apoptosis. | 2012 May | 1 |
6 | 22446485 | Inhibition of Bcl-2 antiapoptotic members by obatoclax potently enhances sorafenib-induced apoptosis in human myeloid leukemia cells through a Bim-dependent process. | 2012 Jun 21 | 1 |
7 | 22952216 | Sorafenib has potent antitumor activity against multiple myeloma in vitro, ex vivo, and in vivo in the 5T33MM mouse model. | 2012 Oct 15 | 3 |
8 | 20015197 | Low-dose taxotere enhances the ability of sorafenib to induce apoptosis in gastric cancer models. | 2011 Feb | 1 |
9 | 20884624 | Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3. | 2010 Nov 1 | 1 |
10 | 17595328 | The multikinase inhibitor sorafenib induces apoptosis in highly imatinib mesylate-resistant bcr/abl+ human leukemia cells in association with signal transducer and activator of transcription 5 inhibition and myeloid cell leukemia-1 down-regulation. | 2007 Sep | 1 |